Haemonetics (HAE) Holder Beaconlight Capital Has Cut Holding by $2.14 Million as Stock Rose; Cisco Systems (CSCO) Holder Brown Brothers Harriman & Co Lifted Position by $803,092 as Stock Value Rose

April 17, 2018 - By David Stenberg

Haemonetics Corporation (NYSE:HAE) Logo

Brown Brothers Harriman & Co increased its stake in Cisco Systems Inc (CSCO) by 24.54% based on its latest 2017Q4 regulatory filing with the SEC. Brown Brothers Harriman & Co bought 21,134 shares as the company’s stock rose 10.71% while stock markets declined. The institutional investor held 107,241 shares of the technology company at the end of 2017Q4, valued at $4.11M, up from 86,107 at the end of the previous reported quarter. Brown Brothers Harriman & Co who had been investing in Cisco Systems Inc for a number of months, seems to be bullish on the $214.89 billion market cap company. The stock increased 3.01% or $1.31 during the last trading session, reaching $44.6. About 15.64M shares traded. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 25.57% since April 17, 2017 and is uptrending. It has outperformed by 14.02% the S&P500.

Ed Bosek decreased its stake in Haemonetics Corp (HAE) by 28.56% based on its latest 2017Q4 regulatory filing with the SEC. Beaconlight Capital Llc sold 36,900 shares as the company’s stock rose 23.57% while stock markets declined. The hedge fund run by Ed Bosek held 92,317 shares of the medical and dental instruments company at the end of 2017Q4, valued at $5.36 million, down from 129,217 at the end of the previous reported quarter. Beaconlight Capital Llc who had been investing in Haemonetics Corp for a number of months, seems to be less bullish one the $4.03B market cap company. The stock increased 0.80% or $0.6 during the last trading session, reaching $75.35. About 204,337 shares traded. Haemonetics Corporation (NYSE:HAE) has risen 82.56% since April 17, 2017 and is uptrending. It has outperformed by 71.01% the S&P500.

Analysts await Haemonetics Corporation (NYSE:HAE) to report earnings on May, 8 before the open. They expect $0.43 EPS, up 10.26% or $0.04 from last year’s $0.39 per share. HAE’s profit will be $22.98 million for 43.81 P/E if the $0.43 EPS becomes a reality. After $0.62 actual EPS reported by Haemonetics Corporation for the previous quarter, Wall Street now forecasts -30.65% negative EPS growth.

Among 10 analysts covering Haemonetics Corporation (NYSE:HAE), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Haemonetics Corporation had 28 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Barrington Research given on Tuesday, July 28. Morgan Stanley maintained Haemonetics Corporation (NYSE:HAE) rating on Thursday, November 9. Morgan Stanley has “Equal-Weight” rating and $51 target. The stock of Haemonetics Corporation (NYSE:HAE) earned “Buy” rating by Jefferies on Monday, January 8. The company was maintained on Thursday, December 21 by Jefferies. Goldman Sachs upgraded Haemonetics Corporation (NYSE:HAE) rating on Monday, May 16. Goldman Sachs has “Neutral” rating and $29 target. The stock of Haemonetics Corporation (NYSE:HAE) earned “Market Perform” rating by CJS Securities on Tuesday, September 20. The firm has “Buy” rating by Jefferies given on Wednesday, February 7. The stock of Haemonetics Corporation (NYSE:HAE) earned “Hold” rating by Benchmark on Thursday, November 5. As per Thursday, August 31, the company rating was maintained by Jefferies. The stock of Haemonetics Corporation (NYSE:HAE) has “Buy” rating given on Wednesday, March 28 by Morgan Stanley.

Since January 2, 2018, it had 0 buys, and 3 insider sales for $484,765 activity. On Tuesday, March 6 Scanlan Jacqueline sold $8,234 worth of Haemonetics Corporation (NYSE:HAE) or 114 shares. 389 shares were sold by Basil Michelle L, worth $28,097 on Tuesday, March 6.

Investors sentiment decreased to 1.11 in 2017 Q4. Its down 0.17, from 1.28 in 2017Q3. It fall, as 20 investors sold HAE shares while 77 reduced holdings. 48 funds opened positions while 60 raised stakes. 50.89 million shares or 3.15% less from 52.55 million shares in 2017Q3 were reported. Hillsdale Mgmt Inc has 23,000 shares for 0.22% of their portfolio. 1,972 are owned by Pnc Financial Group Inc. Hutchin Hill Lp holds 8,000 shares or 0.13% of its portfolio. Brinker Capital Inc holds 0.01% or 5,687 shares in its portfolio. 41,128 are held by State Of Tennessee Treasury Department. Arizona State Retirement Systems, Arizona-based fund reported 88,775 shares. Texas Permanent School Fund reported 35,703 shares. Renaissance Techs Ltd Llc accumulated 977,100 shares or 0.06% of the stock. Tower Rech Cap Ltd Llc (Trc) holds 677 shares or 0.01% of its portfolio. Susquehanna Intl Gp Ltd Liability Partnership holds 4,059 shares. Cornerstone Capital Mngmt Ltd accumulated 29,300 shares or 0.01% of the stock. Citigroup Incorporated has 0% invested in Haemonetics Corporation (NYSE:HAE). Ubs Asset Mgmt Americas holds 0% or 34,389 shares in its portfolio. State Board Of Administration Of Florida Retirement Sys holds 34,043 shares or 0.01% of its portfolio. Bnp Paribas Arbitrage Sa reported 0% of its portfolio in Haemonetics Corporation (NYSE:HAE).

Investors sentiment increased to 1.03 in Q4 2017. Its up 0.01, from 1.02 in 2017Q3. It increased, as 51 investors sold CSCO shares while 660 reduced holdings. 145 funds opened positions while 589 raised stakes. 3.54 billion shares or 1.52% less from 3.60 billion shares in 2017Q3 were reported. Moreover, Rench Wealth Mngmt Inc has 2.9% invested in Cisco Systems, Inc. (NASDAQ:CSCO). Stearns Fincl Services invested in 0.58% or 63,008 shares. Mitchell Mcleod Pugh Williams reported 37,190 shares stake. Abner Herrman And Brock Limited Liability Com holds 45,256 shares. Moreover, Camarda Financial Advsrs Ltd Liability Com has 0.01% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 200 shares. Tiverton Asset Ltd, Delaware-based fund reported 68,957 shares. Creative Planning accumulated 522,560 shares. Milestone Grp Incorporated invested 0.06% in Cisco Systems, Inc. (NASDAQ:CSCO). Green Square Cap Limited Liability stated it has 242,981 shares. 14,899 are owned by Tnb Fincl. Trillium Asset Mngmt Limited Liability Co stated it has 1.11% in Cisco Systems, Inc. (NASDAQ:CSCO). Welch Grp Limited Liability Company owns 51,267 shares. Legg Mason Asset Management (Japan) Limited owns 22,700 shares. Liberty Mutual Asset Mgmt has 199,283 shares. Fukoku Mutual Life stated it has 398,640 shares or 2.3% of all its holdings.

Since December 14, 2017, it had 0 buys, and 5 insider sales for $10.28 million activity. 15,230 shares valued at $578,740 were sold by MCGEARY RODERICK C on Thursday, December 14. BURNS M MICHELE also sold $550,153 worth of Cisco Systems, Inc. (NASDAQ:CSCO) on Monday, February 26. The insider Goeckeler David sold $940,559. On Tuesday, February 20 the insider SARIN ARUN sold $625,751.

Brown Brothers Harriman & Co, which manages about $12.77B and $18.19 billion US Long portfolio, decreased its stake in Occidental Petroleum Corp (NYSE:OXY) by 9,127 shares to 50,109 shares, valued at $3.69M in 2017Q4, according to the filing. It also reduced its holding in State Street Corp (NYSE:STT) by 130,392 shares in the quarter, leaving it with 467,626 shares, and cut its stake in Paypal Holdings Inc.

Among 38 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 26 have Buy rating, 0 Sell and 12 Hold. Therefore 68% are positive. Cisco Systems Inc. had 155 analyst reports since August 4, 2015 according to SRatingsIntel. JP Morgan upgraded it to “Neutral” rating and $27.50 target in Wednesday, April 6 report. The firm earned “Buy” rating on Friday, October 9 by Drexel Hamilton. RBC Capital Markets maintained Cisco Systems, Inc. (NASDAQ:CSCO) rating on Monday, October 9. RBC Capital Markets has “Buy” rating and $36.0 target. The firm earned “Buy” rating on Thursday, June 29 by Robert W. Baird. The stock has “Buy” rating by Raymond James on Thursday, February 15. The firm earned “Buy” rating on Thursday, August 18 by Citigroup. The firm earned “Buy” rating on Tuesday, June 13 by Deutsche Bank. The rating was maintained by Cowen & Co on Thursday, November 16 with “Buy”. The company was maintained on Thursday, May 19 by Barclays Capital. The rating was maintained by Credit Suisse on Thursday, May 19 with “Underperform”.

Haemonetics Corporation (NYSE:HAE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 David Stenberg

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: